search
Back to results

Optimizing mHealth for Adherence Monitoring and Intervention (OAsIS)

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
MERM - medication event reminder monitor
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV/AIDS focused on measuring adherence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age >18 years
  • engagement in HIV care
  • For individuals taking ART:
  • HIV infection per clinic records
  • own a cellular phone

Exclusion Criteria:

  • unwillingness or inability to provide informed consent
  • intention to move >100 km away from KCRC during the three-month study period

Sites / Locations

  • Kabwohe Clinical Research Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Participants using MERM device

Arm Description

Participants will use an electronic medication monitor to measure their adherence to ART in routine clinical care.

Outcomes

Primary Outcome Measures

Adherence to ART

Secondary Outcome Measures

Full Information

First Posted
January 30, 2019
Last Updated
December 9, 2022
Sponsor
Massachusetts General Hospital
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT03825952
Brief Title
Optimizing mHealth for Adherence Monitoring and Intervention
Acronym
OAsIS
Official Title
Optimizing mHealth for Adherence Monitoring and Intervention
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
March 28, 2018 (Actual)
Primary Completion Date
August 5, 2022 (Actual)
Study Completion Date
August 5, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
High and sustained adherence is critical for achieving the individual and public health benefits of HIV antiretroviral therapy (ART). Electronic adherence monitors provide a detailed understanding of adherence and enable real-time interventions. Research has shown the benefit of these monitors and low-cost models have recently become available; however, their use to date has largely been confined to the research context. This study is an implementation science-driven assessment of strategies to improve uptake of electronic adherence monitoring and associated interventions for routine, clinical delivery of ART in Uganda. The study consists of two aims. In Aim 1, the investigators will conduct multi-level formative interviews to design a preliminary implementation strategy. In Aim 2, the investigators will use an iterative approach to optimize the implementation strategy. All work will be guided by the Consolidated Framework for Research Implementation.
Detailed Description
Design: Prospective mixed-method assessment with iterative improvements for program implementation Populations: 1) Health care administrators and clinicians and 2) individuals taking ART Study site: Kabwohe Clinical Research Centre (KCRC) Approach The electronic adherence monitors to be assessed in this study are pill containers that record each opening as a proxy for pill taking behavior. They provide day-to-day information about adherence that can be used to provide informed counseling at clinic visits, as well as SMS reminders and notifications for missed or late doses. For Aim 1, the study team will recruit up to 35 health care administrators and clinicians from various levels of the Ugandan health care system (Health Center IV to the national hospital level), as well as 15 individuals taking ART at the KCRC. Research assistants will conduct individual, in depth qualitative interviews to define a preliminary implementation strategy for these electronic adherence monitors to be used in routine HIV clinical care. In Aim 2 (iteration 1), investigators will deploy the electronic adherence monitors and associated interventions per the strategy identified in Aim 1 among 30 individuals taking ART at the KCRC. Study staff will monitor their adherence for 3 months, during which time they will quantify multiple metrics of the deployment. The investigators will review these metrics with the same health care administrators and clinicians from Aim 1, as well as up to 15 individuals who used the adherence monitors in the Aim 2 deployment. Research assistants will then interview both groups to develop an improved implementation strategy for deployment in a second iteration. In Aim 2 (iteration 2), study staff will utilize the revised implementation strategy to deploy the electronic adherence monitors and associated interventions among a new cohort of 30 individuals taking ART at the KCRC. The study team will then repeat the assessment of the implementation strategy with the same health care administrators and clinicians from Aims 1 and 2 (iteration 1), as well as up to 15 individuals who used the adherence monitors in the Aim 2 (iteration 2) deployment. The investigators will conclude the study with recommendations for wide-scale uptake of this technology in routine HIV clinical care. Aims Aim 1. Define a preliminary implementation strategy for real-time electronic adherence monitoring plus associated interventions for routine HIV clinical care in Uganda Aim 2. Deploy and optimize an implementation strategy for real-time electronic ART adherence monitoring plus associated interventions in routine HIV clinical care in Uganda

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
adherence

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
174 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Participants using MERM device
Arm Type
Experimental
Arm Description
Participants will use an electronic medication monitor to measure their adherence to ART in routine clinical care.
Intervention Type
Device
Intervention Name(s)
MERM - medication event reminder monitor
Intervention Description
The MERM will help measure adherence to ART in routine clinical care.
Primary Outcome Measure Information:
Title
Adherence to ART
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age >18 years engagement in HIV care For individuals taking ART: HIV infection per clinic records own a cellular phone Exclusion Criteria: unwillingness or inability to provide informed consent intention to move >100 km away from KCRC during the three-month study period
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica Haberer, MD, MS
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kabwohe Clinical Research Center
City
Kabwohe
State/Province
Sheema District
Country
Uganda

12. IPD Sharing Statement

Citations:
PubMed Identifier
35937420
Citation
Haberer JE, Baijuka R, Tumuhairwe JB, Tindimwebwa EB, Tinkamanyire J, Tuhanamagyezi E, Musoke L, Garrison LE, DelSignore M, Musinguzi N, Asiimwe S. Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings. Front Digit Health. 2022 Jul 22;4:899643. doi: 10.3389/fdgth.2022.899643. eCollection 2022.
Results Reference
derived
PubMed Identifier
32687473
Citation
Haberer JE, Garrison L, Tumuhairwe JB, Baijuka R, Tindimwebwa E, Tinkamanyire J, Burns BF, Asiimwe S. Factors Affecting the Implementation of Electronic Antiretroviral Therapy Adherence Monitoring and Associated Interventions for Routine HIV Care in Uganda: Qualitative Study. J Med Internet Res. 2020 Sep 10;22(9):e18038. doi: 10.2196/18038.
Results Reference
derived

Learn more about this trial

Optimizing mHealth for Adherence Monitoring and Intervention

We'll reach out to this number within 24 hrs